Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle

Human Molecular Genetics

Volumn 22, Issue 9, 2013, Pages 1856-1866

  Joubert, Romain ^a   Vignaud, Alban ^a   Le, Mickaël ^a   Moal, Christelle ^a   Messaddeq, Nadia ^b   Buj Bello, Anna ^a  

^a GÉNÉTHON   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CELL COUNT; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE EXPRESSION; MITOCHONDRION; MOUSE; MTM1 GENE; MUSCLE WEAKNESS; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SATELLITE CELL; SITE DIRECTED MUTAGENESIS;

EID: 84875913991     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt038     Document Type: Article

References (31)

1. Jungbluth, H., Wallgren-Pettersson, C. and Laporte, J. (2008) Centronuclear (myotubular) myopathy. Orphanet J. Rare Dis., 3, 26.
2. Wallgren-Pettersson, C., Clarke, A., Samson, F., Fardeau, M., Dubowitz, V., Moser, H., Grimm, T., Barohn, R.J. and Barth, P.G. (1995) The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J. Med. Genet., 32, 673-679.
3. Herman, G., Finegold, M., Zhao, W., de Gouyon, B. and Metzenberg, A. (1999) Medical complications in long-term survivors with X-linked myotubular myopathy. J. Pediatr., 134, 206-214.
4. Bevilacqua, J., Bitoun, M., Biancalana, V., Oldfors, A., Stoltenburg, G., Claeys, K.G., Lace'ne, E., Brochier, G., Manéré, L., Laforê t, P. et al. (2009) Necklace fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathol., 117, 283-291.
5. Fardeau, M. (1992) Congenital myopathies. In Mastaglia, F.L. and Detchant, L.W.O. (eds), Skeletal muscle pathology. Churchill Livingstone, Edinburgh, pp. 1488-1531.
6. Laporte, J., Hu, L.J., Kretz, C., Mandel, J.L., Kioschis, P., Coy, J.F., Klauck, S.M., Poustka, A. and Dahl, N. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet., 13, 175-182.
7. Dowling, J.J., Vreede, A.P., Low, S.E., Gibbs, E.M., Kuwada, J.Y., Bonnemann, C.G. and Feldman, E.L. (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet., 5, e1000372.
8. Buj-Bello, A., Laugel, V., Messaddeq, N., Zahreddine, H., Laporte, J., Pellissier, J.F. and Mandel, J.L. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl Acad. Sci. USA, 99, 15060-15065.
9. Pierson, C.R., Dulin-Smith, A.N., Durban, A.N., Marshall, M.L., Marshall, J.T., Snyder, A.D., Naiyer, N., Gladman, J.T., Chandler, D.S., Lawlor, M.W. et al. (2012) Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Hum. Mol. Genet., 21, 811-825.
10. Beggs, A.H., Bohm, J., Snead, E., Kozlowski, M., Maurer, M., Minor, K., Childers, M.K., Taylor, S.M., Hitte, C., Mickelson, J.R. et al. (2010) MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc. Natl Acad. Sci. USA, 107, 14697-14702.
11. Al-Qusairi, L., Weiss, N., Toussaint, A., Berbey, C., Messaddeq, N., Kretz, C., Sanoudou, D., Beggs, A.H., Allard, B., Mandel, J.L. et al. (2009) T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc. Natl Acad. Sci. USA, 106, 18763-18768.
12. Hnia, K., Tronchere, H., Tomczak, K.K., Amoasii, L., Schultz, P., Beggs, A.H., Payrastre, B., Mandel, J.L. and Laporte, J. (2011) Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J. Clin. Invest., 121, 70-85.
13. Dowling, J.J., Joubert, R., Low, S.E., Durban, A.N., Messaddeq, N., Li, X., Dulin-Smith, A.N., Snyder, A.D., Marshall, M.L., Marshall, J.T. et al. (2012) Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Dis. Model Mech., 5, 852-859.
14. Lawlor, M.W., Alexander, M.S., Viola, M.G., Meng, H., Joubert, R., Gupta, V., Motohashi, N., Manfready, R.A., Hsu, C.P., Huang, P. et al. (2012) Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment. Am. J. Pathol., 181, 961-968.
15. Metzger, D. and Feil, R. (1999) Engineering the mouse genome by sire-specific recombination. Curr. Opin. Biotechnol., 10, 470-476.
16. Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K., Pathak, R., Raper, S.E. and Wilson, J.M. (1997) Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med., 3, 306-312.
17. Snyder, R.O., Spratt, S.K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B., Cohen, L.K. and Danos, O. (1997) Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther., 8, 1891-1900.
18. Wu, Z., Asokan, A. and Samulski, R.J. (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol. Ther., 14, 316-327.
19. Kaspar, B.K., Vissel, B., Bengoechea, T., Crone, S., Randolph-Moore, L., Muller, R., Brandon, E.P., Schaffer, D., Verma, I.M., Lee, K.F. et al. (2002) Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc. Natl Acad. Sci. USA, 99, 2320-2325.
20. Glass, D.J. (2003) Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol., 5, 87-90.
21. Sandri, M. (2010) Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am. J. Physiol. Cell Physiol., 298, 1291-1297.
22. Fetalvero, K.M., Yu, Y., Goetschkes, M., Liang, G., Valdez, R.A., Gould, T., Triantafellow, E., Bergling, S., Loureiro, J., Eash, J. et al. (2013) Defective autophagy and mTORC1 signaling in myotubularin null mice. Mol. Cell. Biol., 33, 98-110.
23. Herzog, R.W. (2004) AAV-mediated gene transfer to skeletal muscle. Methods Mol. Biol., 246, 179-194.
24. Loonstra, A., Vooijs, M., Beverloo, H.B., Allak, B.A., van Drunen, E., Kanaar, R., Berns, A. and Jonkers, J. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl Acad. Sci. USA, 98, 9209-9214.
25. Romero, N. (2010) Centronuclear myopathies: a widening concept. Neuromuscul. Disord., 20, 223-228.
26. Pierson, C., Agrawal, P., Blasko, J. and Beggs, A. (2007) Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. Neuromuscul. Disord., 17, 562-568.
27. Conboy, M.J., Cerletti, M., Wagers, A.J. and Conboy, I.M. (2010) Immuno-analysis and FACS sorting of adult muscle fiber-associated stem/ precursor cells. Methods Mol. Biol., 621, 165-173.
28. Razidlo, G.L., Katafiasz, D. and Taylor, G.S. (2011) Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate. J. Biol. Chem., 286, 20005-20019.
29. Robb, S.A., Sewry, C.A., Dowling, J.J., Feng, L., Cullup, T., Lillis, S., Abbs, S., Lees, M.M., Laporte, J., Manzur, A. et al. (2011) Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul. Disord., 21, 379-386.
30. Buj-Bello, A., Fougerousse, F., Schwab, Y., Messaddeq, N., Spehner, D., Pierson, C.R., Durand, M., Kretz, C., Danos, O., Douar, A.M. et al. (2008) AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum. Mol. Genet., 17, 2132-2143.
31. Castets, P., Bertrand, A.T., Beuvin, M., Ferry, A., Le Grand, F., Castets, M., Chazot, G., Rederstorff, M., Krol, A., Lescure, A. et al. (2011) Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency. Hum. Mol. Genet., 20, 694-704.